Pelvital (Flyte) Company
.jpg)
Pelvital is a privately held medical technology company focused on women’s health. Pelvital’s vision is to significantly improve the lives of people who suffer from pelvic floor disorders through novel, evidence-based, easy-to-use products offered directly to consumers via Flytetherapy.com and in partnership with clinicians. Founded in Minnesota in 2016 with roots in Norway, the company is focused on expanding conservative treatment options.
Pelvital’s first product, Flyte®, is a clinically proven, in-home treatment for pelvic floor muscle strengthening and bladder control. Paired with expert education and encouragement from our on-staff pelvic floor physical therapists or our partners, Flyte is the proven effective, simple solution for women who want to treat at home and improve quality of life.
Pelvital’s first product, Flyte®, is a clinically proven, in-home treatment for pelvic floor muscle strengthening and bladder control. Paired with expert education and encouragement from our on-staff pelvic floor physical therapists or our partners, Flyte is the proven effective, simple solution for women who want to treat at home and improve quality of life.
Industry:
Pelvic & Uterine Healthcare
Headquarters:
Minneapolis, Minnesota, United States
Founded Date:
01-01-2016
Employees Number:
1-10
Total Funding:
$1,797,736
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-02-18
Last Funding Type:
Debt Financing
Register and Claim Ownership